Ham-Ak Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
About Ham-Ak Pharmaceuticals
Ham-Ak Pharmaceuticals Private Limited (HPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 08 July 2021 (Three years and six months 22 days old ). Its registered office is in Nagaon, Assam, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Inamul Hassan, Haidor Ali, and Ikramul Hussain serve as directors at the Company.
Company Details
- Location
Nagaon, Assam, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24299AS2021PTC021573
- Company No.
021573
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jul 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Who are the key members and board of directors at Ham-Ak Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Inamul Hassan  | Director | 08-Jul-2021 | Current |
| Haidor Ali | Director | 08-Jul-2021 | Current |
| Ikramul Hussain | Director | 08-Jul-2021 | Current |
Financial Performance of Ham-Ak Pharmaceuticals.
Ham-Ak Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ham-Ak Pharmaceuticals?
Unlock access to Ham-Ak Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sirajul Memorial FoundationInamul Hassan and Ikramul Hussain are mutual person
Mamtaz FoundationInamul Hassan, Haidor Ali and 1 more are mutual person
Imran FoundationInamul Hassan, Haidor Ali and 1 more are mutual person
Ham-Ak Right News Assam Media Private LimitedInamul Hassan, Haidor Ali and 1 more are mutual person
- Faruk Abdullah Foundation
Inamul Hassan and Ikramul Hussain are mutual person
- Ham-Ak Foundation
Inamul Hassan and Haidor Ali are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ham-Ak Pharmaceuticals?
Ham-Ak Pharmaceuticals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ham-Ak Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ham-Ak Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.